These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25906547)

  • 1. [Hormone replacement therapy and venous thromboembolism].
    Pavičić Baldani D; Skrgatić L; Simunić V; Elvedi Gasparović V; Geršak B
    Lijec Vjesn; 2015; 137(1-2):34-40. PubMed ID: 25906547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
    Canonico M
    Maturitas; 2015 Nov; 82(3):304-7. PubMed ID: 26276103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis.
    Scarabin PY
    Climacteric; 2018 Aug; 21(4):341-345. PubMed ID: 29570359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EMAS position statement: Managing menopausal women with a personal or family history of VTE.
    Tremollieres F; Brincat M; Erel CT; Gambacciani M; Lambrinoudaki I; Moen MH; Schenck-Gustafsson K; Vujovic S; Rozenberg S; Rees M;
    Maturitas; 2011 Jun; 69(2):195-8. PubMed ID: 21489728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormones and venous thromboembolism among postmenopausal women.
    Scarabin PY
    Climacteric; 2014 Dec; 17 Suppl 2():34-7. PubMed ID: 25223916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone therapy and venous thromboembolism among postmenopausal women.
    Scarabin PY
    Front Horm Res; 2014; 43():21-32. PubMed ID: 24943295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestogens and venous thromboembolism among postmenopausal women using hormone therapy.
    Canonico M; Plu-Bureau G; Scarabin PY
    Maturitas; 2011 Dec; 70(4):354-60. PubMed ID: 22024394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
    Bergendal A; Kieler H; Sundström A; Hirschberg AL; Kocoska-Maras L
    Menopause; 2016 Jun; 23(6):593-9. PubMed ID: 27023862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
    Canonico M; Oger E; Plu-Bureau G; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
    Circulation; 2007 Feb; 115(7):840-5. PubMed ID: 17309934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens.
    Scarabin PY; Hemker HC; Clément C; Soisson V; Alhenc-Gelas M
    Menopause; 2011 Aug; 18(8):873-9. PubMed ID: 21487317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone therapy and thromboembolic disease.
    Battaglioli T; Martinelli I
    Curr Opin Hematol; 2007 Sep; 14(5):488-93. PubMed ID: 17934355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone therapy and recurrence of venous thromboembolism among postmenopausal women.
    Olié V; Plu-Bureau G; Conard J; Horellou MH; Canonico M; Scarabin PY
    Menopause; 2011 May; 18(5):488-93. PubMed ID: 21178641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study.
    Canonico M; Oger E; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
    J Thromb Haemost; 2006 Jun; 4(6):1259-65. PubMed ID: 16706969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone therapy and venous thromboembolism.
    Peverill RE
    Best Pract Res Clin Endocrinol Metab; 2003 Mar; 17(1):149-64. PubMed ID: 12763518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
    Lacut K; Oger E
    Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
    Canonico M; Scarabin PY
    Climacteric; 2009; 12 Suppl 1():76-80. PubMed ID: 19811247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
    Rovinski D; Ramos RB; Fighera TM; Casanova GK; Spritzer PM
    Thromb Res; 2018 Aug; 168():83-95. PubMed ID: 29936403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review.
    Goldštajn MŠ; Mikuš M; Ferrari FA; Bosco M; Uccella S; Noventa M; Török P; Terzic S; Laganà AS; Garzon S
    Arch Gynecol Obstet; 2023 Jun; 307(6):1727-1745. PubMed ID: 35713694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What's new in hormone replacement therapy: focus on transdermal estradiol and micronized progesterone.
    Simon JA
    Climacteric; 2012 Apr; 15 Suppl 1():3-10. PubMed ID: 22432810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy and venous thromboembolism.
    Eisenberger A; Westhoff C
    J Steroid Biochem Mol Biol; 2014 Jul; 142():76-82. PubMed ID: 24007716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.